Mammalian: A stable, high-productivity CHO cell line can be generated within 19 weeks using a robust cell line development platform. Integrated serum-free medium screening enables consistent gram-level productivity. Project experience spans multiple mammalian expression systems.

The development workflow also incorporates single-cell cloning, clone screening, and cell line stability assessment to support the selection of suitable producer clones for subsequent process development.

Microbial: High-throughput screening, extensive strain libraries, and a synthetic biology–guided platform support scalable production across microbial systems, including E. coli and yeast.